← All candidates
13 insider filings on record.
J. French HillFinancial Services · Intelligencetraded 31 Dec 2025 · filed 23 Jan · selfSold$15K–$50Kself31 Dec 2025260d ago23 Jan237d ago19 filings on record.
SOLVSolventum Corp
NYSE · Healthcare · $12.91B
$90.11
-1.37% · Sep 16
13 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$12.91B
Float
147.1M
85% public
Short % float
Pro
Congress
▸ Disclosures lag trades by 30–45 days.
1 disclosure12 mo
MemberTradeAmountOwnerTradedFiled
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
8 more transactions on Pro →Context
Wall St
$93.92 avg target
+4.2% vs today · 13 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q2 '26$2.55 act+$0.64
Q1 '26$1.48 act+$0.13
Q4 '25$1.57 act+$0.07
Q3 '25$1.50 act+$0.07
Coverage
Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue?Zacks · 1w agoShould Investors Buy SOLV as Growth Improves but Debt Risks Persist?Zacks · 2w ago3 Reasons to Avoid SOLV and 1 Stock to Buy InsteadStockStory · 2w agoSOLV Plans Health Information Systems Business Spinoff to Drive GrowthZacks · 08-14
The file stays open
19 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice